Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesDividends payablesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for cbdMD (YCBD) over the last 10 years, with Q3 2025 value amounting to $735672.0.

  • cbdMD's Accumulated Expenses rose 1627.98% to $735672.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $735672.0, marking a year-over-year increase of 1627.98%. This contributed to the annual value of $735672.0 for FY2025, which is 1627.98% up from last year.
  • Latest data reveals that cbdMD reported Accumulated Expenses of $735672.0 as of Q3 2025, which was up 1627.98% from $1.1 million recorded in Q2 2025.
  • cbdMD's 5-year Accumulated Expenses high stood at $3.1 million for Q4 2023, and its period low was $609674.0 during Q1 2025.
  • Its 5-year average for Accumulated Expenses is $1.7 million, with a median of $1.7 million in 2021.
  • As far as peak fluctuations go, cbdMD's Accumulated Expenses skyrocketed by 6908.04% in 2021, and later tumbled by 7498.94% in 2024.
  • Quarter analysis of 5 years shows cbdMD's Accumulated Expenses stood at $1.9 million in 2021, then skyrocketed by 38.82% to $2.7 million in 2022, then grew by 17.06% to $3.1 million in 2023, then tumbled by 74.99% to $775946.0 in 2024, then dropped by 5.19% to $735672.0 in 2025.
  • Its Accumulated Expenses stands at $735672.0 for Q3 2025, versus $1.1 million for Q2 2025 and $609674.0 for Q1 2025.